The surge in investment in health tech is more than just a blow

Investment in healthcare technology surged 47% last year, hitting a new high of $ 51 billion in 2020.

Venture capital (VC) funding was particularly strong across the sector, with $ 17 billion available in a new healthcare-focused venture fund.

According to Pitchbook, investment in nanomedicine alone has increased 2.5-fold over the past five years. The investment monitoring platform also said that global funding for digital health and telemedicine in 2020 increased 45% year-on-year, while equity financing for digital health companies reached a record $ 26.5 billion last year. I reported.

Rather than being “shot in the arms” led by COVID-19, such growth supports the long-term healthcare industry’s prediction that it will be worth more than $ 10 trillion by 2022.

Since January 2021, £ 3.79 billion has been invested in technology companies that not only provide disruptive innovations specifically related to pandemic protection and readiness, but also impact a wider range of applications and global health. It was. COVID Decade “.

The world needs this great boost to avoid getting caught up in future pandemics, but it also democratizes and decentralizes health care through early detection diagnostics, precision medicine and early intervention therapies that transform the world’s health. Creating new opportunities.

This will create a more sustainable point-of-care based healthcare ecosystem, making it more affordable and accessible to, for example, any healthcare professional.

The message has already been picked up. Healthcare start-ups raised a record $ 80.6 billion in equity funding in 2020, with general investment in the sector increasing for the third straight quarter since the outbreak, according to a recent report by technology market analysis specialist CB Insights. And contributed to the promotion of intense innovation.

Some experts say that while vaccines are being developed at an unprecedented rate, the sector has advanced for 10 years in just six months, and new data-driven technologies and digitization techniques are being used further. Suggests. Research and deployment of the Pfizer and AstraZeneca COVID-19 vaccines was the fastest in history.

The test has also improved. Innova Medical Group, the largest manufacturer of immunochromatography, has produced an LFT with at least 99.99% specificity in just 30 minutes to display the results. These simple tests use colloidal gold nanoparticles and are currently manufactured and supplied in countries around the world, with a focus on the United Kingdom, which is currently building world-class testing and vaccine programs.

Professor Michael Mina of Harvard University is a leading advocate of frequent mass testing to stop the spread of viral infections using LFT in the community and at work, saying:

“Rapid tests on the market are a big step forward. This means that some people have immediate access to the tests they are craving for to know their condition, without going through a doctor.”

The world’s first new national health agency was also launched in the United Kingdom in April 2021 with a focus on preventing and responding to external health threats such as infectious diseases.

The UK Health Security Agency (UKHSA) protects against future health threats and takes over the COVID-19 pandemic response from the UK Public Health Service (PHE) and NHS Test and Trace. This includes the use of data analysis and genome monitoring capabilities for both tissues, in addition to scale testing and contract tracking capabilities.

But much more is needed to avoid repeated devastation of COVID-19, which has killed 2.74 million people and has had more serious financial, health and social consequences.

With an estimated $ 5.6 trillion in global GDP lost, the World Bank states that the global recession has been the most serious since World War II, twice as deep as the 2008 financial crisis. Mental health problems, unemployment and poverty are all increasing, and many of the people underlying life-threatening illnesses have not been diagnosed.

And the world is still surprisingly not ready for another outbreak. The Royal Society of Chemistry claims that of the 220 viruses known to infect humans, only 10 have clinically approved antiviral drugs that can be used to combat them. So, it is reported that two new viruses spread to human hosts every year in the last century.

The latest World Health Organization report shows that the current coronavirus has transmitted to humans through bats and other animals. This will continue, and investing in technology to analyze these trends is essential.

According to Graham Watson, executive chair at Scottish Health Innovations Ltd, avoiding future pandemics also requires immediate support for innovation. Graham Watson predicts a future where healthcare innovation, rapid development and early hiring will become routine.

“If modern healthcare innovation continues to grow at a post-pandemic pace, having an“ optimal investment ecosystem ”is essential to drive that progress. “

Despite increased investment and innovation, processes also need to evolve to address healthcare. The Lancet, a leading medical journal, showed how a pre-COVID R & D readiness ecosystem gap was discovered in a 2020 assessment by the Global Preparedness Monitoring Board.

The report clarified the need for features that ensure rapid manufacturing and distribution during a pandemic. Wait times also needed to be reduced so that innovators and scientists could develop new products faster. This is a very attractive approach for investment funds.

Lancet said: “A true end-to-end R & D ecosystem needs to deliver the products we need to people on a large scale as quickly as possible, in a globally fair and equitable manner.”

Investing in healthcare may not be the only way to stay ahead of the next outbreak. Ending logging and wildlife trade will protect us from animal diseases that are transmitted to humans. Investing to prevent these actions can stop the outbreak in the first place.

Paul Sheedy, co-founder of the non-profit World Nano Foundation, advocates continued investment in nanotechnology for better healthcare and pandemic protection.

“Healthcare innovation is more exciting than ever, new technologies and techniques are being developed and constantly improving. Healthcare investment growth during COVID-19 is remarkable, but needs to be maintained. there is.

“To date, 2.74 million people have died in this pandemic, the global economy has fallen into recession, unemployment and poverty have increased significantly, and cases of suicide and mental health have increased. Many are life-threatening. You may be left undiagnosed with the COVID protocol.

“Continuous and efficient investment that allows innovators access to critical capital at a faster rate is critical to developing healthcare innovations that can prevent and fight future pandemics.”

A new health tech fund was launched by the Vector Innovation Fund in March to raise the first $ 300 million for a subfund for pandemic protection and future healthcare, precision medicine, advanced points of care and sustainability. Focuses on AI technology that supports a variety of healthcare. World economy and human lifespan.

World Nano Foundation Is a non-profit membership organization with 75,000 subscribers and users in 40 countries, working on the international commercialization of nanoscale technology in 16 industry sectors, working with various partners, We make the most of the support and funding that brings advanced technology to the world and commerce. It is supported by many industry and academic groups that develop and create legacy to enable innovation.

Vector Innovation Fund (VIF) Is a Reserved Alternative Investment Fund (RAIF) that specializes in supporting technology companies that can transform and protect the global market and achieve technology, sustainability, and longevity in line with UN SDG principles, especially in global health care. is. VIF’s first sub-fund focuses on “pandemic protection” and preparation for future healthcare technologies. This fund structure is located in the world-famous Luxemburg jurisdiction and is an internationally recognized professional investment such as Family Office, UHNW, Private Investors, Pension Funds, International Banks, ESG Investors and Sovereign Wealth Funds. Only available at home. General Partners have a strong track record in industry, healthcare, technology and investment, have 21 exits and generate a total value of $ 2.4 billion, including the success of two IPOs.

The surge in investment in health tech is more than just a blow

Source link The surge in investment in health tech is more than just a blow

Hair Transplant Cost In Indore, Breast Implant Surgery In Indore, Cosmetic Surgeon In Nashik, Best Gynecologist In Indore, Microtia Surgery in India

Back to top button